Medical Devices & Tech


1655 Roberts Boulevard N.W.
Kennesaw, GA 30144 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Development of implantable biological devices, surgical adhesives, and biomaterials

Management Steven G. Anderson, Chairman, President and Chief Executive Officer; Bruce G. Anderson, Vice President, U.S. Sales and Marketing; Jeffrey W. Burris, Esq., Vice President and General Counsel; Scott B. Capps, Vice President, Clinical Research; David M. Fronk, Vice President, regulatory Affairs and Quality Assurance

Click here for Financial Data
Keywords: contemporary, implantable, adhesives, biomaterials, cardiac


Updated: Aug. 22, 2013


CryoLife is a contemporary biological medical device company that, since its founding in 1984, has been focused on the development of implantable biological devices, surgical adhesives, and biomateria......view more

Products / Services

CryoLife's human tissue preservation service draws revenue through cardiac and vascular allograft tissue preservation. A substantial portion of CryoLife's R&D efforts are focused on Protein Hydrogel ......view more

Technology / Differentiation

BioGlue is the first Protein Hydrogel Technologies product to be commercially introduced into world markets. BioGlue is a two-component surgical adhesive designed for cardiovascular, vascular, pulmona...view more

Market / Customers

Over 75% of all cardiovascular procedures involving allograft (homograft) tissue in the U.S. are performed with cryopreserved human heart valves from CryoLife. The company distributes its tissue to i......view more


Aurazyme Pharmaceuticals, a wholly owned subsidiary of CryoLife, is focusing on the development of novel drug therapies for cardiovascular and cancer treatment....view more


CryoLife's R&D efforts are focused on Protein Hydrogel Technologies (BioDisc for spinal repair and BioFoam for abdominal aortic aneurysms and severe wounds) and Antigen Reduction Technologies (bovine ...view more